Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle (Q40596481)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 2001
edit
Language Label Description Also known as
English
Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle
scientific article published on September 2001

    Statements

    Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle (English)
    M Boogaerts
    D J Winston
    E J Bow
    G Garber
    A C Reboli
    A P Schwarer
    N Novitzky
    A Boehme
    E Chwetzoff
    K De Beule
    Itraconazole Neutropenia Study Group
    1 September 2001
    412-422

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit